News – Page 50 – Endpoints News

Senate Democrats say RFK Jr.'s divestment plans are 'plainly inadequate' ahead of Tuesday vote

4 months ago

Thermo Fisher to lay off 300 workers at two viral vector factories

4 months ago

Irish startup reports mid-stage victory for short-acting psychedelic drug in depression

4 months ago

Drugmakers seize on biomarkers to test the FDA's rare disease shift

4 months ago

Sionna seeks $135M IPO to fuel tests of cystic fibrosis drug candidates

4 months ago

Tectonic to raise $185M; Acelyrin drops rights to Affibody drug

4 months ago

Exclusive: German biotech declares Phase 2 win for non-opioid drug for neuropathic pain

4 months ago

Australian biotech AdvanCell nabs $112M Series C for radiopharmaceuticals

4 months ago

Updated: Drug prices likely to soar due to Trump tariffs, pharma bodies warn

4 months ago

J&J’s Rybrevant gets CHMP backing weeks after FDA rejection

4 months ago

Pfizer says new colorectal cancer data could support full approval of Braftovi

4 months ago

RFK Jr. hearings leave key GOP senator “struggling”; Drugmakers report Q4 earnings; Leerink builds healthcare M&A ...

4 months ago

RFK Jr. evades questions on vaccines and autism in written responses to senators

4 months ago

AbbVie executives bask in Skyrizi, Rinvoq successes as the drugs take up Humira's mantle

4 months ago

Genentech joins suits against STD clinics it says get 'unlawful' 340B discounts

4 months ago

After more deliberation, England agrees to pay for Vertex’s gene therapy for sickle cell disease

4 months ago

AstraZeneca scraps UK vaccine site expansion after government budget cuts

4 months ago

Daiichi Sankyo taps new CEO, aims to build up ADC franchise

4 months ago

Celltrion looks to buy US facilities to sidestep potential Trump tariffs

4 months ago

AbbVie raises Skyrizi and Rinvoq estimates, predicts $31B in 2027 sales

4 months ago

Roche separates CFO, informatics posts; Lilly execs land at Kailera, Neurocrine

4 months ago

Updated: Novartis claims best earnings in years, validating shift to pure-play strategy

4 months ago

Friday IPO doubleheader from Maze and Metsera brings life to biotech debuts

4 months ago

Vertex's non-opioid pain drug is approved by FDA, bringing first of new class to market

4 months ago

First page Previous page 47 48 495051 52 53 Next page Last page